CNTN-1 Upregulation Induced by Low-Dose Cisplatin Promotes Malignant Progression of Lung Adenocarcinoma Cells via Activation of Epithelial-Mesenchymal Transition

CNTN-1 Upregulation Induced by Low-Dose Cisplatin Promotes Malignant Progression of Lung Adenocarcinoma Cells via Activation of Epithelial-Mesenchymal Transition

Tumor metastasis and invasion are the main impediments to lung adenocarcinoma successful treatment. Previous studies demonstrate that chemotherapeutic agents can elevate the malignancy of cancer cells other than their therapeutic effects. In this study, the effects of transient low-dose cisplatin tr...

Full description

Bibliographic Details
Main Authors:	Ruijie Zhang, Shengjin Li, Jian Lan, Changyi Li, Xianzhi Du, Weijie Dong, Qian Yu, Daoxin Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-05-01
Series:	Frontiers in Genetics
Subjects:	CNTN-1 EMT cisplatin A549 cell metastasis invasion
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2022.891665/full

Similar Items

CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway
by: Ruijie Zhang, et al.
Published: (2017-09-01)

DCBLD2 Mediates Epithelial-Mesenchymal Transition-Induced Metastasis by Cisplatin in Lung Adenocarcinoma
by: Xiaosu Chen, et al.
Published: (2021-03-01)

Heterogeneity of Cell Surface Glutamate and GABA Receptor Expression in Shank and CNTN4 Autism Mouse Models
by: Christopher Heise, et al.
Published: (2018-06-01)

Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance
by: Milad Ashrafizadeh, et al.
Published: (2020-06-01)

Case Report: A Case of Epileptic Disorder Associated With a Novel CNTN2 Frameshift Variant in Homozygosity due to Maternal Uniparental Disomy
by: Wenjie Chen, et al.
Published: (2021-10-01)

Ablation of CNTN2+ Pyramidal Neurons During Development Results in Defects in Neocortical Size and Axonal Tract Formation
by: Maria Eleni Kastriti, et al.
Published: (2019-11-01)

Efficiency of combining pomegranate juice with low-doses of cisplatin and taxotere on A549 human lung adenocarcinoma cells
by: Nasser Mohamad, et al.
Published: (2018-01-01)

Whole exome sequencing identified five novel variants in CNTN2, CARS2, ARSA, and CLCN4 leading to epilepsy in consanguineous families
by: Angham Abdulrhman Abdulkareem, et al.
Published: (2023-06-01)

Familial Psychosis Associated With a Missense Mutation at MACF1 Gene Combined With the Rare Duplications DUP3p26.3 and DUP16q23.3, Affecting the CNTN6 and CDH13 Genes
by: Josep Pol-Fuster, et al.
Published: (2021-04-01)

Inhibitory Effects of 3-Cyclopropylmethoxy-4-(difluoromethoxy) Benzoic Acid on TGF-β1-Induced Epithelial–Mesenchymal Transformation of In Vitro and Bleomycin-Induced Pulmonary Fibrosis In Vivo
by: Tianxiao Sun, et al.
Published: (2023-03-01)

Combination Effect of Cilengitide with Erlotinib on TGF-β1-Induced Epithelial-to-Mesenchymal Transition in Human Non-Small Cell Lung Cancer Cells
by: Jisu Jeong, et al.
Published: (2022-03-01)

Inhibition of TIGAR Increases Exogenous p53 and Cisplatin Combination Sensitivity in Lung Cancer Cells by Regulating Glycolytic Flux
by: Jiaying Fu, et al.
Published: (2022-12-01)

Inhibition of Glucose-6-Phosphate Dehydrogenase Reverses Cisplatin Resistance in Lung Cancer Cells via the Redox System
by: Weipeng Hong, et al.
Published: (2018-01-01)

TonEBP/NFAT5 expression is associated with cisplatin resistance and migration in macrophage-induced A549 cells
by: Hee Ju Song, et al.
Published: (2024-03-01)

ROS-Nrf2 pathway mediates the development of TGF-β1-induced epithelial-mesenchymal transition through the activation of Notch signaling
by: Kai Yazaki, et al.
Published: (2021-09-01)

NBM-T-BMX-OS01, an Osthole Derivative, Sensitizes Human Lung Cancer A549 Cells to Cisplatin through AMPK-Dependent Inhibition of ERK and Akt Pathway
by: Tian-Jun Chen, et al.
Published: (2015-06-01)

A Systematic Review and Meta-Analysis of Autoantibodies for Diagnosis and Prognosis in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
by: Xiaoqian Guo, et al.
Published: (2021-05-01)

Pomegranate Juice Extract Decreases Cisplatin Toxicity on Peripheral Blood Mononuclear Cells
by: Mohamad Nasser, et al.
Published: (2020-10-01)

Effects of cilengitide derivatives on TGF-β1-induced epithelial-to-mesenchymal transition and invasion in gefitinib-resistant non-small cell lung cancer cells
by: Yujin Seo, et al.
Published: (2023-10-01)

Contactin 1: An Important and Emerging Oncogenic Protein Promoting Cancer Progression and Metastasis
by: Yan Gu, et al.
Published: (2020-07-01)

Puerarin Enhances the Anti-Tumor Effect of Cisplatin on Drug-Resistant A549 Cancer in vivo and in vitro Through Activation of the Wnt Signaling Pathway
by: Huang P, et al.
Published: (2020-07-01)

Upregulation of CD109 Promotes the Epithelial-to-Mesenchymal Transition and Stemness Properties of Lung Adenocarcinomas via Activation of the Hippo-YAP Signaling
by: Kang-Yun Lee, et al.
Published: (2020-12-01)

Interplay between Partial EMT and Cisplatin Resistance as the Drivers for Recurrence in HNSCC
by: Julia Ingruber, et al.
Published: (2022-10-01)

The Role of Contactin 1 in Cancers: What We Know So Far
by: Yumei Liang, et al.
Published: (2020-10-01)

Bixin and fuxoxanthin alone and in combination with cisplatin regulate ABCC1 and ABCC2 Transcription in A549 Lung Cancer Cells
by: Ferdy Chandra, et al.
Published: (2023-01-01)

Chemical Investigation of Diketopiperazines and N-Phenethylacetamide Isolated from <i>Aquimarina</i> sp. MC085 and Their Effect on TGF-β-Induced Epithelial–Mesenchymal Transition
by: Myong Jin Lee, et al.
Published: (2021-09-01)

Epithelial to Mesenchymal Transition in Patients with Pancreatic Ductal Adenocarcinoma: State-of-the-Art and Therapeutic Opportunities
by: Julie Dardare, et al.
Published: (2021-07-01)

ROS-Induced DCTPP1 Upregulation Contributes to Cisplatin Resistance in Ovarian Cancer
by: Yu Wang, et al.
Published: (2022-02-01)

Beta-Caryophyllene Enhances the Anti-Tumor Activity of Cisplatin in Lung Cancer Cell Lines through Regulating Cell Cycle and Apoptosis Signaling Molecules
by: Emad A. Ahmed, et al.
Published: (2022-11-01)

Overexpression of Contactin 1 promotes growth, migration and invasion in Hs578T breast cancer cells
by: Nan Chen, et al.
Published: (2018-04-01)

Zyxin inhibits the epithelial–mesenchymal transition process in gastric cancer by upregulating SIRT1
by: Jing Lou, et al.
Published: (2023-10-01)

Amifostine enhances the resistance of renal proximal tubular epithelial cells to cisplatin by upregulating PKM2
by: XUE Rong, et al.
Published: (2023-03-01)

Editorial: Epithelial to Mesenchymal Plasticity in Colorectal Cancer
by: Federico Bocci, et al.
Published: (2022-06-01)

Dusp6 inhibits epithelial-mesenchymal transition in endometrial adenocarcinoma via ERK signaling pathway
by: Fan Ming-Jun, et al.
Published: (2019-09-01)

Cell cycle-specific phosphorylation of p53 protein in A549 cells exposed to cisplatin and standardized air pollutants
by: Agata Niechoda, et al.
Published: (2023-08-01)

Cisplatin Induced Nephrotoxicity
by: Seyed Seifollah Beladi Mousavi, et al.
Published: (2014-02-01)

ARNTL2 is an indicator of poor prognosis, promotes epithelial-to-mesenchymal transition and inhibits ferroptosis in lung adenocarcinoma
by: Huan Zhang, et al.
Published: (2022-12-01)

Epithelial-mesenchymal transition promotes reactivity of human lung adenocarcinoma A549 cells to CpG ODN
by: Koichi Kobayashi, et al.
Published: (2016-09-01)

The crosstalk between anoikis and epithelial-mesenchymal transition and their synergistic roles in predicting prognosis in colon adenocarcinoma
by: Jiahui Zhou, et al.
Published: (2023-06-01)

Comparative Study of Transcriptomics-Based Scoring Metrics for the Epithelial-Hybrid-Mesenchymal Spectrum
by: Priyanka Chakraborty, et al.
Published: (2020-03-01)